Europe Digital Twins in Healthcare Market Report Scope & Overview:

The Europe Digital Twins in Healthcare Market was valued at USD 0.62 Billion in 2025 and is projected to reach USD 17.65 Billion by 2035, registering a CAGR of 39.82% from 2026 to 2035.

The Europe Digital Twins in Healthcare Market continues to expand as a long-standing medical-technology manufacturing base and growing digital-health infrastructure investment across Germany, the United Kingdom and France reinforce regional adoption. Regional regulatory harmonization under the European Medicines Agency continues supporting cross-border digital-twin platform deployment within the bloc, lowering the administrative burden of serving multiple member states from a single technology platform.

Growing EU precision-medicine policy support and national digital-health modernization programs are pulling additional investment into both hospital-operations and patient-specific digital-twin applications across the continent. Deep medical-device engineering talent pools across several member states further reinforce Europe's manufacturing and technology competitiveness, and expanding collaboration between health systems and technology vendors is gradually widening the range of clinical applications incorporating simulation-based modeling.

⮞Atos expanded its healthcare digital-twin consulting and systems-integration practice across Germany and France in early 2026, reinforcing continued European investment in hospital-operations and research-oriented simulation platforms.

Global Digital Twins in Healthcare Market Size

The Global Digital Twins in Healthcare Market was USD 2.22 billion in 2025, and the projected market size in 2035 would be USD 69.67 billion, growing at a CAGR of 41.17% from 2026 to 2035. The main driver behind such a significant growth rate is the rapid adoption of AI-enabled personalized medicine, predictive healthcare modeling, and virtual simulations.

By Type, Process & System Digital Twin Dominates the Europe Digital Twins in Healthcare Market, Product Digital Twin Grows Fastest

Process & System Digital Twin solutions dominated European demand, reflecting hospitals' early focus on operational efficiency gains that deliver measurable cost savings without requiring regulatory clearance for patient-facing clinical use. Large German and UK hospital networks continue favoring process-level twins as the natural entry point for building internal digital-twin expertise before expanding into patient-specific clinical applications. Established health-information-technology budgets across member states further reinforce this segment's dominant revenue contribution relative to newer product-level applications still gaining regulatory traction. Growing availability of off-the-shelf operational-twin software is further lowering adoption barriers for smaller hospitals across member states.

Product Digital Twins are expected to have the highest growth rate owing to increasing use of virtual twins in the development and post-market surveillance process among European medical device manufacturers. Increasing interest of EMA in using digital twins in device validation will further drive the average growth rate of the Product Digital Twins, particularly for implantable and surgical devices for which physical testing is expensive. The cooperation of German device manufacturers with software providers of simulations is also speeding up the adoption of Product Digital Twins in Europe.

⮞In February 2025, Dassault Systèmes began beta testing a configurable, AI-powered Living Heart virtual twin designed to model individual patients and patient populations, supporting medical-device development and the virtual evaluation of treatments.

By Application, Personalized Medicine Dominates the Europe Digital Twins in Healthcare Market, Drug Discovery Grows Fastest

Personalized Medicine applications dominated European demand as health systems increasingly deploy patient-specific digital twins to model individualized treatment responses across oncology, cardiology and chronic-disease management. Growing clinician confidence in simulation-informed treatment planning, reinforced by outcomes data accumulating at leading German and UK academic medical centers, continues strengthening this application's position as the largest regional revenue contributor. Expanding integration between electronic health records and digital-twin platforms is further embedding personalized-medicine applications into routine clinical workflows across member states. Growing payer interest in outcomes-based reimbursement is additionally reinforcing demand for simulation-informed care across the continent.

Drug Discovery applications are forecast to grow fastest as European pharmaceutical developers increasingly use patient-population digital twins to simulate trial outcomes and reduce late-stage clinical failure rates. Growing adoption of virtual control arms and in-silico trial design is reinforcing this above-average growth trajectory across both large originator companies and smaller biotech sponsors concentrated in major European biotech hubs. Expanding collaboration between drug developers and specialized simulation-software vendors is further accelerating demand for drug-discovery-focused capacity across member states. Rising EMA openness to simulation-supported submissions is further reinforcing this application's growth outlook.

⮞In January 2025, French medtech company PrediSurge announced a collaboration with Medtronic to offer SmartPlan Pro, using patient-specific digital-twin simulations to assess endoleak risks and support planning for endovascular aortic aneurysm repair.

By End-use, Hospitals and Clinics Dominate the Europe Digital Twins in Healthcare Market, Clinical Research Organizations Grow Fastest

Hospitals and Clinics accounted for the largest end-use share across Europe, reflecting their position as both the primary adopters and largest potential beneficiaries of operational and patient-specific digital-twin applications. Established capital budgets for health-information-technology investment across large German and UK hospital networks continue reinforcing this segment's dominant revenue contribution. Multi-facility hospital networks across member states are particularly well positioned to justify digital-twin investment given the scale economies available across shared modeling platforms. Growing administrator familiarity with simulation-based planning tools is further reinforcing this segment's adoption advantage across large hospital networks.

Clinical Research Organizations are forecast to grow fastest as European CROs increasingly offer digital-twin-enabled trial design services to differentiate themselves in a competitive outsourced-research market. Growing sponsor demand for faster, lower-cost trial execution is reinforcing this above-average growth trajectory, particularly for CROs serving smaller biotech companies without in-house simulation expertise. Expanding partnerships between European CROs and digital-twin technology vendors are further widening the range of trial designs incorporating simulation-based modeling across member states. Growing numbers of first-time sponsors are further reinforcing this segment's growth outlook across the continent's outsourced-research industry.

⮞In September 2025, Belgium-based Oxurion announced that its subsidiary Axiodis CRO was developing a digital-twin and virtual-patient program to support clinical trials, alongside AI integration into its proprietary Exagis electronic case-report-form solution.

Regional Analysis

Germany Digital Twins in Healthcare Market Insights

Germany dominated the Europe Digital Twins in Healthcare Market with the largest revenue share of approximately 29.45% in 2025, supported by a large medical-device manufacturing base and established health-technology ecosystem built up over decades. Siemens Healthineers' and Atos's continued platform-expansion activity continues reinforcing Germany's leadership position across nearly every application tracked in this report. A deep base of specialty health-technology suppliers across the country further reinforces this entrenched manufacturing advantage. Federal supply-chain resilience reviews have further elevated the strategic priority placed on domestic digital-health infrastructure.

Continued government support for digital-health modernization, growing originator investment in domestic simulation technology, and a deep base of medical-device engineering talent reinforce Germany's dominance within Europe. Rising investment in hospital-operations and research-oriented digital-twin platforms is expected to keep Germany the region's primary revenue engine through the remainder of the decade. Several German states continue competing directly for new health-technology investment through targeted incentive programs. Expanding domestic workforce training programs are also helping address skilled-labor constraints at newer technology sites.

⮞In October 2025, Fraunhofer ITWM reported progress on the EU-funded AI4Lungs project, including the introduction of a digital-twin platform that uses patient data to simulate lung-disease scenarios and support individualized treatment-pathway recommendations.

United Kingdom Digital Twins in Healthcare Market Insights

The United Kingdom is expected to grow at the fastest CAGR of about 41.68% from 2026-2035, facilitated by growing National Health Service interest in digital-health modernization and rising venture investment among specialty health-technology startups. Expanding life-sciences sector funding is reinforcing the UK's above-regional growth trajectory as domestic hospital networks scale digital-twin pilot programs for both operational and clinical use. Growing collaboration between UK academic research centers and specialty health-technology companies is further widening the domestic pipeline. Expanding domestic workforce training initiatives are further helping address skilled-labor constraints at newer UK technology sites.

Continued UK government funding for digital-health infrastructure, combined with growing collaboration between domestic technology vendors and European health systems, is supporting faster-than-average volume growth across the country through the forecast period. Expanding cross-border collaboration with EU member states is expected to reinforce this pattern through the remainder of the decade as UK vendors continue aligning platforms with European regulatory requirements and technical standards across the National Health Service. Rising government grant funding for digital-health infrastructure projects is additionally reinforcing investor confidence.

⮞In September 2025, NHS England announced plans for NHS Online, a digitally connected hospital service designed to link patients with specialist clinicians nationwide and coordinate diagnostic appointments through digital channels, reflecting the expansion of digitally enabled care infrastructure across England.

France and Rest of Europe Digital Twins in Healthcare Market Insights

France held a meaningful share of European revenue, anchored by Atos's and Dassault Systèmes's established technology infrastructure and the country's position as a hub for medical-device simulation software serving health-system customers across the continent. Continued government investment in digital-health innovation is expected to further reinforce France's position through the forecast period. Deep regional expertise in engineering-simulation software further reinforces France's premium technology-vendor positioning across the continent. A favorable research-tax-credit environment further continues attracting new technology-vendor investment into the country.

The broader Rest of Europe grouping, including Spain, Italy and Poland, contributed additional demand through established hospital-network adoption and growing specialty health-technology clusters. Continued European Union investment in digital-health modernization programs should keep regional demand climbing across these markets through the forecast period. Growing collaboration between Spanish and Italian hospital networks and regional technology vendors is further widening the Rest of Europe supplier base. Rising government incentive funding across several smaller EU member states is additionally supporting new specialty health-technology investment.

⮞In June 2026, Dassault Systèmes and PariSanté Campus announced a collaboration giving eligible French healthcare startups access to virtual-twin technology, AI capabilities, sovereign cloud infrastructure and accelerator programs to help advance healthcare innovations toward industrial deployment.

⮞In January 2025, the EU-funded DTRIP4H consortium launched in Estonia with €11.9 million in Horizon Europe funding to develop a decentralized healthcare digital-twin environment using generative AI and virtual-reality technologies for research infrastructure and personalized healthcare.

Market Dynamics

Growth Drivers: Digital-Health Modernization and Originator Platform Investment

The European industry is driven by growing EU interest in digital-health modernization, continued originator investment in regional simulation-platform capacity, and rising government funding for domestic health-technology infrastructure across Germany and the United Kingdom. As health authorities prioritize both cost containment and improved clinical outcomes, demand for regionally sourced digital-twin platforms continues rising.

Siemens Healthineers's continued platform-expansion activity and Atos's continued consulting-practice growth are reinforcing this driver by demonstrating sustained originator and technology-vendor confidence in regional simulation capacity. Expanding collaboration between health systems and European technology vendors is further widening the addressable customer base able to justify early capacity investment.

⮞In February 2026, Germany's Federal Ministry of Health updated its “Gemeinsam Digital 2026” strategy, prioritizing broader use of health data, AI-enabled applications and digital care processes, alongside stronger connections to the European Health Data Space.

Restraints: High Implementation Costs and Data-Integration Complexity

High implementation and integration costs continue restraining faster capacity expansion across Europe, as building accurate digital-twin models requires substantial investment in sensors, data infrastructure and specialized modeling expertise before measurable returns materialize. Many smaller European hospitals continue lacking the capital and technical staff needed to deploy digital-twin platforms at meaningful scale.

Data-integration complexity across fragmented electronic health record systems also complicates digital-twin deployment decisions for health systems operating multiple legacy platforms across member states. Because validating a new digital-twin application against real-world clinical outcomes can take several years, some hospitals continue favoring narrower, lower-risk operational pilots over broader patient-specific clinical deployment.

Opportunities: EU Precision-Medicine Funding and Cross-Border Platform Expansion

Growing EU funding programs aimed at precision-medicine and digital-health modernization represent a significant opportunity across Europe, as governments increasingly prioritize improving clinical outcomes alongside cost containment. Manufacturers positioned early in regional capacity expansion stand to capture meaningful share as digital-health modernization investment continues through the forecast period.

Expansion into cross-border digital-twin platform deployment offers a second opportunity for European manufacturers able to leverage EMA regulatory harmonization to serve multiple member states from a single technology platform. Continued collaboration between health systems and regional technology vendors is expected to further accelerate this opportunity.

⮞In July 2026, the European Commission's health-policy platform convened stakeholders to identify practical pathways for integrating virtual human twins and AI into healthcare, including discussions of procurement, payer perspectives and adoption barriers that could inform cross-border commercialization strategies.

Europe Digital Twins in Healthcare Companies are:

• Siemens Healthineers AG

• Dassault Systèmes SE

• Philips Healthcare

• Atos SE

• Virtonomy GmbH

• PrediSurge

• InSilicoTrials Technologies, Inc.

• ANSYS, Inc.

• Microsoft Corporation

• IBM Corporation

• Oracle Corporation

• NVIDIA Corporation

• Hewlett Packard Enterprise Company

• GE Healthcare Technologies Inc.

• Altair Engineering Inc.

• Unlearn.AI, Inc.

• Twin Health, Inc.

• Q Bio, Inc.

• Faststream Technologies

• Cortex Labs

Europe Digital Twins in Healthcare Market Report Scope: